HCV NEW INHIBITORS
HCV Progress in Therapy with Novel Sialomimetic-chimeric inhibitors
| Coordinator | National Institute For Chemical Pharmaceutical Research and Development ; DUKE CHEM SA ; THERAPICON ; Aurigon Life Science GmbH ; PHARMA SERV INTERNATIONAL SRL ; 3S PHARMACOLOGICAL CONSULTATION & RES.SRL ; CYATHUS EXQUIRERE PHARMAFORSCHUNGSGMBH ; Università degli Studi del Piemonte Orientale |
| Grant period | 2013-10-01 - 2015-09-30 |
| Funding body | European Union |
| Call number | FP7-SME-2012 |
| Grant number | 315322 |
| Identifier | G:(EU-Grant)315322 |